Proteon Therapeutics' Series C Round

Proteon Therapeutics raised a round of funding on August 11, 2011.

Proteon Therapeutics is a biopharmaceutical company developing PRT-201, a human recombinant protein that aims to permanently dilate segments of blood vessels, blocks vasospasm, and reduce the formatio…

Articles about Proteon Therapeutics' Series C Round: